Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial (Q42211649)
Jump to navigation
Jump to search
scientific article published on 4 June 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial |
scientific article published on 4 June 2014 |
Statements
1 reference
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial (English)
1 reference
1 reference
Gregory J Dore
1 reference
Ira M Jacobson
1 reference
Graham R Foster
1 reference
Michael W Fried
1 reference
Monica Radu
1 reference
Vladimir V Rafalsky
1 reference
Monika Peeters
1 reference
Oliver Lenz
1 reference
Sivi Ouwerkerk-Mahadevan
1 reference
Guy De La Rosa
1 reference
Ronald Kalmeijer
1 reference
Jane Scott
1 reference
Rekha Sinha
1 reference
Maria Beumont-Mauviel
1 reference
4 June 2014
1 reference
1 reference
384
1 reference
9941
1 reference
403-413
1 reference
Identifiers
1 reference
1 reference